Krystal Biotech Inc (KRYS) — Long-term Investment Intensity
Krystal Biotech Inc (KRYS) has a Long-term Investment Intensity of 17.1% as of June 2026. Long-term investments of $257.29 Million represent 17.1% of total assets of $1.50 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Krystal Biotech Inc to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Krystal Biotech Inc Long-term Investment Intensity (2019–2025)
This chart shows how Krystal Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2025. As of June 2026, the intensity stands at 17.1%, reflecting long-term investments of $257.29 Million against total assets of $1.50 Billion USD. For the complete balance sheet picture, see balance sheet size of Krystal Biotech Inc.
Annual Long-term Investment Intensity for Krystal Biotech Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Krystal Biotech Inc from 2019 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read KRYS current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 9.6% | $128.07 Million | $1.33 Billion | ▼ -4.8 pp |
| 2024 | 14.4% | $152.11 Million | $1.06 Billion | ▲ +6.8 pp |
| 2023 | 7.6% | $61.95 Million | $818.36 Million | ▲ +6.7 pp |
| 2022 | 0.8% | $4.62 Million | $558.45 Million | ▼ -9.5 pp |
| 2021 | 10.3% | $64.37 Million | $626.29 Million | ▲ +10.0 pp |
| 2019 | 0.2% | $497.00K | $209.02 Million | — |